Journal article
Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
Clinical chemistry (Baltimore, Md.), Vol.69(8), pp.777-784
08/02/2023
DOI: 10.1093/clinchem/hvad079
PMCID: PMC12376297
PMID: 37562009
Abstract
Numerous laboratory tests are used in the diagnosis and management of patients with diabetes mellitus. The quality of the scientific evidence supporting the use of these assays varies substantially. An expert committee compiled evidence-based recommendations for laboratory analysis in patients with diabetes. The overall quality of the evidence and the strength of the recommendations were evaluated. The draft consensus recommendations were evaluated by invited reviewers and presented for public comment. Suggestions were incorporated as deemed appropriate by the authors (see Acknowledgments in the full version of the guideline). The guidelines were reviewed by the Evidence Based Laboratory Medicine Committee and the Board of Directors of the American Association of Clinical Chemistry and by the Professional Practice Committee of the American Diabetes Association.
Diabetes can be diagnosed by demonstrating increased concentrations of glucose in venous plasma or increased hemoglobin A1c (Hb A1c) in the blood. Glycemic control is monitored by the patients measuring their own blood glucose with meters and/or with continuous interstitial glucose monitoring devices and also by laboratory analysis of Hb A1c. The potential roles of noninvasive glucose monitoring; genetic testing; and measurement of ketones, autoantibodies, urine albumin, insulin, proinsulin, and C-peptide are addressed.
The guidelines provide specific recommendations based on published data or derived from expert consensus. Several analytes are found to have minimal clinical value at the present time, and measurement of them is not recommended.
Details
- Title: Subtitle
- Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
- Creators
- David B Sacks - National Institutes of HealthMark Arnold - University of Iowa, Fraternal Order of Eagles Diabetes Research CenterGeorge L Bakris - University of ChicagoDavid E Bruns - Department of Pathology, University of Virginia Medical School, Charlottesville, VA, United StatesAndrea R Horvath - New South Wales Health Pathology Department of Chemical Pathology, Prince of Wales Hospital, Sydney, AustraliaÅke Lernmark - Department of Clinical Sciences, Lund University/CRC, Skane University Hospital Malmö, Malmö, SwedenBoyd E Metzger - Division of Endocrinology, Northwestern University, The Feinberg School of Medicine, Chicago, IL, United StatesDavid M Nathan - Massachusetts General Hospital Diabetes Center and Harvard Medical School, Boston, MA, United StatesM Sue Kirkman - Department of Medicine, University of North Carolina, Chapel Hill, NC, United States
- Resource Type
- Journal article
- Publication Details
- Clinical chemistry (Baltimore, Md.), Vol.69(8), pp.777-784
- DOI
- 10.1093/clinchem/hvad079
- PMID
- 37562009
- PMCID
- PMC12376297
- NLM abbreviation
- Clin Chem
- ISSN
- 1530-8561
- eISSN
- 1530-8561
- Grant note
- name: National Institutes of Health Intramural Research Program
- Language
- English
- Date published
- 08/02/2023
- Academic Unit
- Pharmaceutical Sciences and Experimental Therapeutics; Center for Biocatalysis and Bioprocessing; Fraternal Order of Eagles Diabetes Research Center; Chemistry
- Record Identifier
- 9984473208802771
Metrics
15 Record Views